Results 191 to 200 of about 45,216 (237)

Exploring the potential mechanisms of sorafenib resistance in hepatocellular carcinoma cell lines based on RNA sequencing. [PDF]

Cancer Cell Int
Sun M, Zhang Z, Chen C, Zhong J, Long Z, Shen L, Huang H, Lu J.   +7 more
europepmc   +1 more source

Optimal therapy for patients with hepatocellular carcinoma and resistance or intolerance to sorafenib: challenges and solutions

, 2017
Emily M. Ray, Hanna K. Sanoff
openalex   +2 more sources

Mechanisms of Reversible Sorafenib Resistance in Hepatocellular Carcinoma

, 2016
Elizabeth A. Kuczynski
openalex   +1 more source

Correction: Cancer-associated fibroblasts induce sorafenib resistance of hepatocellular carcinoma cells through CXCL12/FOLR1. [PDF]

BMC Cancer
Zhao J, Lin E, Bai Z, Jia Y, Wang B, Dai Y, Zhuo W, Zeng G, Liu X, Cai C, Li P, Zou B, Li J.   +12 more
europepmc   +1 more source

CSF3R-AS promotes hepatocellular carcinoma progression and sorafenib resistance through the CSF3R/JAK2/STAT3 positive feedback loop. [PDF]

Cell Death Dis
Feng Z, Gao Y, Cai C, Tan J, Liu P, Chen Y, Deng G, Ouyang Y, Liu X, Cao K, Zeng S, Han Y, Deng X, Shen H.   +13 more
europepmc   +1 more source

The Emerging Role of Long Noncoding RNAs in Sorafenib Resistance Within Hepatocellular Carcinoma. [PDF]

Cancers (Basel)
Vij P, Hussain MS, Satapathy SK, Cobos E, Tripathi MK.   +4 more
europepmc   +1 more source

NOTCH1 regulates the DNA damage response and sorafenib resistance by activating ATM in hepatocellular carcinoma. [PDF]

Am J Transl Res
Liu J, Yu Y, Xu B, Liang Q, Fang T, Zhou N, Sun G.   +6 more
europepmc   +1 more source

Autophagy modulation attenuates sorafenib resistance in HCC induced in rats. [PDF]

Cell Death Dis
Elleithi Y, El-Gayar A, Amin MN.
europepmc   +1 more source

Retraction Note: The miR-30a-5p/CLCF1 axis regulates sorafenib resistance and aerobic glycolysis in hepatocellular carcinoma. [PDF]

Cell Death Dis
Zhang Z, Tan X, Luo J, Yao H, Si Z, Tong JS.   +5 more
europepmc   +1 more source

Emodin reverses sorafenib resistance in hepatocellular carcinoma by inhibiting epithelial-mesenchymal transition via the Akt signaling pathway. [PDF]

Transl Cancer Res
Wang Q, Zhang J.
europepmc   +1 more source